Gulmurod Khalimov

Recent publications · Crossref

5 total works indexed

1. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

   · 2021 · cited 569x

2. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

   · 2018 · cited 221x

3. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

   · 2022 · cited 177x

4. Decidability of Parameterized Verification

   · 2015 · cited 111x

5. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

   · 2023 · cited 86x

via Crossref · CC0

Wikidata facts